Sirt1 activation ameliorates renal fibrosis by inhibiting the TGF-β/Smad3 pathway

Journal of Cellular Biochemistry

Volumn 115, Issue 5, 2014, Pages 996-1005

  Huang, Xin Zhong ^a,b   Wen, Donghai ^a   Zhang, Min ^a   Xie, Qionghong ^a   Ma, Leting ^a   Guan, Yi ^a   Ren, Yueheng ^a   Chen, Jing ^a   Hao, Chuan Ming ^a  

^a FUDAN UNIVERSITY   (China)

^b NANTONG UNIVERSITY   (China)

Author keywords

CHRONIC KIDNEY DISEASE; FIBROSIS; RESVERATROL; Sirt1

Indexed keywords

COLLAGEN TYPE 1; CREATININE; FIBRONECTIN; LENTIVIRUS VECTOR; NITROGEN; RESVERATROL; SCLEROPROTEIN; SHORT HAIRPIN RNA; SIRTUIN 1; SMAD3 PROTEIN; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA1; UREA;

ACETYLATION; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CHRONIC KIDNEY FAILURE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DEACETYLATION; DOWN REGULATION; EXTRACELLULAR MATRIX; GENE OVEREXPRESSION; GENE SILENCING; GENETIC TRANSCRIPTION; GLOMERULOSCLEROSIS; HUMAN; HUMAN CELL; IMMUNOPRECIPITATION; IN VIVO STUDY; KIDNEY FIBROSIS; MALE; MESANGIUM CELL; MOUSE; NEPHRECTOMY; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN DEFICIENCY; PROTEIN PHOSPHORYLATION; PROTEIN URINE LEVEL; PROTEINURIA; QUANTITATIVE ANALYSIS; RAT; REAL TIME POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; UREA NITROGEN BLOOD LEVEL; WESTERN BLOTTING;

CHRONIC KIDNEY DISEASE; FIBROSIS; RESVERATROL; SIRT1;

ANIMALS; FIBROSIS; HUMANS; MICE; RATS; RENAL INSUFFICIENCY, CHRONIC; SIGNAL TRANSDUCTION; SIRTUIN 1; SMAD3 PROTEIN; STILBENES; TRANSFORMING GROWTH FACTOR BETA1;

EID: 84895535457     PISSN: 07302312     EISSN: 10974644     Source Type: Journal    
DOI: 10.1002/jcb.24748     Document Type: Article

References (48)

1. Alcendor RR, Gao S, Zhai P, Zablocki D, Holle E, Yu X, Tian B, Wagner T, Vatner SF, Sadoshima J,. 2007. Sirt1 regulates aging and resistance to oxidative stress in the heart. Circ Res 100: 1512-1521.
2. Amat R, Planavila A, Chen SL, Iglesias R, Giralt M, Villarroya F,. 2009. SIRT1 controls the transcription of the peroxisome proliferator-activated receptor-gamma Co-activator-1alpha (PGC-1alpha) gene in skeletal muscle through the PGC-1alpha autoregulatory loop and interaction with MyoD. J Biol Chem 284: 21872-21880.
3. Anekonda TS, Adamus G,. 2008. Resveratrol prevents antibody-induced apoptotic death of retinal cells through upregulation of Sirt1 and Ku70. BMC Res Notes 1: 122.
4. Aubin MC, Lajoie C, Clement R, Gosselin H, Calderone A, Perrault LP,. 2008. Female rats fed a high-fat diet were associated with vascular dysfunction and cardiac fibrosis in the absence of overt obesity and hyperlipidemia: Therapeutic potential of resveratrol. J Pharmacol Exp Ther 325: 961-968.
5. Badid C, Vincent M, McGregor B, Melin M, Hadj-Aissa A, Veysseyre C, Hartmann DJ, Desmouliere A, Laville M,. 2000. Mycophenolate mofetil reduces myofibroblast infiltration and collagen III deposition in rat remnant kidney. Kidney Int 58: 51-61.
6. Border WA, Noble NA,. 1997. TGF-beta in kidney fibrosis: A target for gene therapy. Kidney Int 51: 1388-1396.
7. Bottinger EP, Bitzer M,. 2002. TGF-beta signaling in renal disease. J Am Soc Nephrol 13: 2600-2610.
8. Brunet A, Sweeney LB, Sturgill JF, Chua KF, Greer PL, Lin Y, Tran H, Ross SE, Mostoslavsky R, Cohen HY, Hu LS, Cheng HL, Jedrychowski MP, Gygi SP, Sinclair DA, Alt FW, Greenberg ME,. 2004. Stress-dependent regulation of FOXO transcription factors by the SIRT1 deacetylase. Science 303: 2011-2015.
9. Chen J, Boyle S, Zhao M, Su W, Takahashi K, Davis L, Decaestecker M, Takahashi T, Breyer MD, Hao CM,. 2006. Differential expression of the intermediate filament protein nestin during renal development and its localization in adult podocytes. J Am Soc Nephrol 17: 1283-1291.
10. Chen J, Zhao M, Rao R, Inoue H, Hao CM,. 2005. C/EBP{beta} and its binding element are required for NF{kappa}B-induced COX2 expression following hypertonic stress. J Biol Chem 280: 16354-16359.
11. Chen SJ, Yuan W, Mori Y, Levenson A, Trojanowska M, Varga J,. 1999. Stimulation of type I collagen transcription in human skin fibroblasts by TGF-beta: Involvement of Smad 3. J Invest Dermatol 112: 49-57.
12. Cheng HL, Mostoslavsky R, Saito S, Manis JP, Gu Y, Patel P, Bronson R, Appella E, Alt FW, Chua KF,. 2003. Developmental defects and p53 hyperacetylation in Sir2 homolog (SIRT1)-deficient mice. Proc Natl Acad Sci USA 100: 10794-10799.
13. Chung AC, Zhang H, Kong YZ, Tan JJ, Huang XR, Kopp JB, Lan HY,. 2010. Advanced glycation end-products induce tubular CTGF via TGF-beta-independent Smad3 signaling. J Am Soc Nephrol 21: 249-260.
14. Costa Cdos S, Hammes TO, Rohden F, Margis R, Bortolotto JW, Padoin AV, Mottin CC, Guaragna RM,. 2010. SIRT1 transcription is decreased in visceral adipose tissue of morbidly obese patients with severe hepatic steatosis. Obes Surg 20: 633-639.
15. Das C, Lucia MS, Hansen KC, Tyler JK,. 2009. CBP/p300-mediated acetylation of histone H3 on lysine 56. Nature 459: 113-117.
16. Dennler S, Itoh S, Vivien D, ten Dijke P, Huet S, Gauthier JM,. 1998. Direct binding of Smad3 and Smad4 to critical TGF beta-inducible elements in the promoter of human plasminogen activator inhibitor-type 1 gene. EMBO J 17: 3091-3100.
17. Flanders KC,. 2004. Smad3 as a mediator of the fibrotic response. Int J Exp Pathol 85: 47-64.
18. Hao CM, Haase VH,. 2010. Sirtuins and their relevance to the kidney. J Am Soc Nephrol 21: 1620-1627.
19. Hariharan N, Maejima Y, Nakae J, Paik J, Depinho RA, Sadoshima J,. 2010. Deacetylation of FoxO by Sirt1 plays an essential role in mediating starvation-induced autophagy in cardiac myocytes. Circ Res 107: 1470-1482.
20. Hashem MA, Jun KY, Lee E, Lim S, Choo HY, Kwon Y,. 2008. A rapid and sensitive screening system for human type I collagen with the aim of discovering potent anti-aging or anti-fibrotic compounds. Mol Cells 26: 625-630.
21. He W, Wang Y, Zhang MZ, You L, Davis LS, Fan H, Yang HC, Fogo AB, Zent R, Harris RC, Breyer MD, Hao CM,. 2010. Sirt1 activation protects the mouse renal medulla from oxidative injury. J Clin Invest 120: 1056-1068.
22. Inanaga K, Ichiki T, Matsuura H, Miyazaki R, Hashimoto T, Takeda K, Sunagawa K,. 2009. Resveratrol attenuates angiotensin II-induced interleukin-6 expression and perivascular fibrosis. Hypertens Res 32: 466-471.
23. Inoue Y, Itoh Y, Abe K, Okamoto T, Daitoku H, Fukamizu A, Onozaki K, Hayashi H,. 2007. Smad3 is acetylated by p300/CBP to regulate its transactivation activity. Oncogene 26: 500-508.
24. Kitada M, Takeda A, Nagai T, Ito H, Kanasaki K, Koya D,. 2011. Dietary restriction ameliorates diabetic nephropathy through anti-inflammatory effects and regulation of the autophagy via restoration of Sirt1 in diabetic Wistar fatty (fa/fa) rats: A model of type 2 diabetes. Exp Diabetes Res 2011: 908185.
25. Kume S, Haneda M, Kanasaki K, Sugimoto T, Araki S, Isono M, Isshiki K, Uzu T, Kashiwagi A, Koya D,. 2006. Silent information regulator 2 (SIRT1) attenuates oxidative stress-induced mesangial cell apoptosis via p53 deacetylation. Free Radic Biol Med 40: 2175-2182.
26. Kume S, Haneda M, Kanasaki K, Sugimoto T, Araki S, Isshiki K, Isono M, Uzu T, Guarente L, Kashiwagi A, Koya D,. 2007. SIRT1 inhibits transforming growth factor beta-induced apoptosis in glomerular mesangial cells via Smad7 deacetylation. J Biol Chem 282: 151-158.
27. Li J, Qu X, Ricardo SD, Bertram JF, Nikolic-Paterson DJ,. 2010. Resveratrol inhibits renal fibrosis in the obstructed kidney: Potential role in deacetylation of Smad3. Am J Pathol 177: 1065-1071.
28. Liu Y,. 2006. Renal fibrosis: New insights into the pathogenesis and therapeutics. Kidney Int 69: 213-217.
29. Meng XM, Huang XR, Chung AC, Qin W, Shao X, Igarashi P, Ju W, Bottinger EP, Lan HY,. 2010. Smad2 protects against TGF-beta/Smad3-mediated renal fibrosis. J Am Soc Nephrol 21: 1477-1487.
30. Park SJ, Ahmad F, Philp A, Baar K, Williams T, Luo H, Ke H, Rehmann H, Taussig R, Brown AL, Kim MK, Beaven MA, Burgin AB, Manganiello V, Chung JH,. 2012. Resveratrol ameliorates aging-related metabolic phenotypes by inhibiting cAMP phosphodiesterases. Cell 148: 421-433.
31. Planavila A, Iglesias R, Giralt M, Villarroya F,. 2011. Sirt1 acts in association with PPARalpha to protect the heart from hypertrophy, metabolic dysregulation, and inflammation. Cardiovasc Res 90: 276-284.
32. Queen BL, Tollefsbol TO,. 2010. Polyphenols and aging. Curr Aging Sci 3: 34-42.
33. Rasouri S, Lagouge M, Auwerx J,. 2007. SIRT1/PGC-1: A neuroprotective axis. Med Sci (Paris) 23: 840-844.
34. Roberts AB, Russo A, Felici A, Flanders KC,. 2003. Smad3: A key player in pathogenetic mechanisms dependent on TGF-beta. Ann N Y Acad Sci 995: 1-10.
35. Roberts AB, Tian F, Byfield SD, Stuelten C, Ooshima A, Saika S, Flanders KC,. 2006. Smad3 is key to TGF-beta-mediated epithelial-to-mesenchymal transition, fibrosis, tumor suppression and metastasis. Cytokine Growth Factor Rev 17: 19-27.
36. Salminen A, Kaarniranta K,. 2009. NF-kappaB signaling in the aging process. J Clin Immunol 29: 397-405.
37. Schnaper HW, Hayashida T, Poncelet AC,. 2002. It's a Smad world: Regulation of TGF-beta signaling in the kidney. J Am Soc Nephrol 13: 1126-1128.
38. Shi Y, Massague J,. 2003. Mechanisms of TGF-beta signaling from cell membrane to the nucleus. Cell 113: 685-700.
39. Simonsson M, Kanduri M, Gronroos E, Heldin CH, Ericsson J,. 2006. The DNA binding activities of Smad2 and Smad3 are regulated by coactivator-mediated acetylation. J Biol Chem 281: 39870-39880.
40. Tanno M, Kuno A, Yano T, Miura T, Hisahara S, Ishikawa S, Shimamoto K, Horio Y,. 2010. Induction of manganese superoxide dismutase by nuclear translocation and activation of SIRT1 promotes cell survival in chronic heart failure. J Biol Chem 285: 8375-8382.
41. Thevenet L, Mejean C, Moniot B, Bonneaud N, Galeotti N, Aldrian-Herrada G, Poulat F, Berta P, Benkirane M, Boizet-Bonhoure B,. 2004. Regulation of human SRY subcellular distribution by its acetylation/deacetylation. EMBO J 23: 3336-3345.
42. Vaziri H, Dessain SK, Ng Eaton E, Imai SI, Frye RA, Pandita TK, Guarente L, Weinberg RA,. 2001. hSIR2(SIRT1) functions as an NAD-dependent p53 deacetylase. Cell 107: 149-159.
43. Vindevoghel L, Lechleider RJ, Kon A, de Caestecker MP, Uitto J, Roberts AB, Mauviel A,. 1998. SMAD3/4-dependent transcriptional activation of the human type VII collagen gene (COL7A1) promoter by transforming growth factor beta. Proc Natl Acad Sci USA 95: 14769-14774.
44. Wang W, Huang XR, Canlas E, Oka K, Truong LD, Deng C, Bhowmick NA, Ju W, Bottinger EP, Lan HY,. 2006. Essential role of Smad3 in angiotensin II-induced vascular fibrosis. Circ Res 98: 1032-1039.
45. Wang W, Koka V, Lan HY,. 2005. Transforming growth factor-beta and Smad signalling in kidney diseases. Nephrology 10: 48-56.
46. Wilson BJ, Tremblay AM, Deblois G, Sylvain-Drolet G, Giguere V,. 2010. An acetylation switch modulates the transcriptional activity of estrogen-related receptor alpha. Mol Endocrinol 24: 1349-1358.
47. Yuan F, Xie Q, Wu J, Bai Y, Mao B, Dong Y, Bi W, Ji G, Tao W, Wang Y, Yuan Z,. 2011. MST1 promotes apoptosis through regulating Sirt1-dependent p53 deacetylation. J Biol Chem 286: 6940-6945.
48. Zhang Q, Qiu J, Li H, Lu Y, Wang X, Yang J, Wang S, Zhang L, Gu Y, Hao CM, Chen J,. 2011. Cyclooxygenase 2 promotes parathyroid hyperplasia in ESRD. J Am Soc Nephrol 22: 664-672.